Skip to content
2000
Volume 18, Issue 16
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Vaccinations have been given to people for at least 100 years of which 80 years formulated in adjuvants. Currently, aluminium- containing formulas and the oil-based substance called MF59 are the two adjuvants licensed for clinical use. Despite the massive use of aluminium adjuvant, its mechanism of action has been only recently addressed. In this review, we will discuss both the cellular and molecular mode of action of aluminium-containing adjuvants.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/138161212800166004
2012-06-01
2025-04-09
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/138161212800166004
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test